ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 199 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2020. The put-call ratio across all filers is 0.51 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $257,000 | -38.8% | 7,575 | -26.3% | 0.03% | -32.0% |
| Q2 2021 | $420,000 | -1.2% | 10,275 | -2.6% | 0.05% | +2.0% |
| Q1 2021 | $425,000 | -31.9% | 10,550 | 0.0% | 0.05% | -31.0% |
| Q4 2020 | $624,000 | +78.8% | 10,550 | +45.5% | 0.07% | +69.0% |
| Q3 2020 | $349,000 | +79.9% | 7,250 | +81.2% | 0.04% | +75.0% |
| Q2 2020 | $194,000 | +74.8% | 4,000 | 0.0% | 0.02% | +50.0% |
| Q1 2020 | $111,000 | +54.2% | 4,000 | +66.7% | 0.02% | +100.0% |
| Q4 2019 | $72,000 | – | 2,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $20,334,212 | 13.72% |
| BERYLSON CAPITAL PARTNERS, LLC | 228,000 | $1,529,880 | 4.32% |
| Eagle Health Investments LP | 1,214,860 | $8,151,711 | 1.52% |
| Matrix Capital Management Company, LP | 11,572,590 | $77,652,079 | 0.90% |
| Triatomic Management LP | 121,166 | $813,024 | 0.83% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $201,257,781 | 0.82% |
| Aristotle Atlantic Partners, LLC | 3,104,961 | $20,834,288 | 0.78% |
| Pier Capital, LLC | 737,589 | $4,949,222 | 0.71% |
| ARK Investment Management | 10,453,752 | $70,144,675 | 0.46% |
| Nikko Asset Management Americas, Inc. | 6,384,047 | $42,773,115 | 0.45% |